患者モニタリングデバイス市場：製品別（EEG、MEG、TCD、パルスオキシメーター、スパイロメーター、胎児モニター、体温モニター、MCOT、ECG、ICP、ILR、マルチパラメーターモニター、体重モニタリング）、エンドユーザー別（病院、ASC） - 2027年までの世界市場予測

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

患者モニタリング機器市場は、2022年の423億米ドルから2027年には654億米ドルに達し、CAGR9.1％で成長すると予測されます。市場の成長は主に、バイオセンサーやコネクテッドケアデバイスの採用拡大、在宅・家庭用... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年9月21日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	378	390	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

患者モニタリング機器市場は、2022年の423億米ドルから2027年には654億米ドルに達し、CAGR9.1％で成長すると予測されます。市場の成長は主に、バイオセンサーやコネクテッドケアデバイスの採用拡大、在宅・家庭用製品の需要増に起因しています。しかし、新規かつ高度なモニタリングデバイスに関連する高コストが、市場の成長を制限すると予想されます。

"製品セグメントでは、血糖値モニタリングシステムセグメントが2027年までに大きな成長を遂げるだろう。"

患者モニタリング装置市場は、製品に基づき、マルチパラメータモニタリング装置、体温モニタリング装置、血糖値モニタリングシステム、胎児および新生児モニタリング装置、神経モニタリング装置、体重モニタリング装置、心臓モニタリング装置、血行動態／血圧モニタリング装置、呼吸モニタリング装置、その他の患者モニタリング装置に区分されます。この分野の大幅な成長は、連続グルコースモニタリングシステムの技術的進歩や継続的な製品承認、市場における自己モニタリングシステムに対する連続モニタリングシステムの利点に起因しています。連続グルコースモニタリングシステムは、非侵襲的な検出、検出時間の短縮、コストの削減など、自己血糖値測定システムに対する幅広い利点を提供します。これらの利点は、連続グルコースモニタリングシステムが提供する他のいくつかの利点と一緒に、この製品分野の成長につながるでしょう。

「エンドユーザー別では、病院が患者監視装置市場の主要なシェアを占めると予想されます。
エンドユーザー別では、患者モニタリングデバイス市場は、在宅介護環境、病院、外来手術センター、その他のエンドユーザーに区分されます。病院の需要の伸びは、患者の治療、診断、訓練を受けた人材、疾病管理のための最先端のサービスの瞬間的な可用性に起因し、主要国の病院数の増加や病院ベースのケアのための安定した需要を確保している。病院ではより多くの診断やスクリーニングが行われ、市場シェアの拡大を促進しています。病院は他の医療施設と比較して患者の流入が多いため、これも市場拡大の主要な要因となっています。

"地域別では、アジア太平洋地域の患者監視装置市場が2027年までに最も高いCAGRで成長すると予測されています。"
アジア太平洋地域は、医療費の増加、感染症の大きな負担、老年人口の増加、医療インフラ全体に対する公的・私的貢献の好影響などにより、予測期間中に最も高いCAGRで成長するものと思われます。また、外来手術センターの増加や病院のインフラ整備も、患者監視装置市場を牽引するものと期待されています。

本レポートで参照した主な参加企業の内訳は以下のとおりです。
- 企業タイプ別ティア1-45%, ティア2-34%, ティア3-21
- 役職別役職別：Cレベル-47%、ディレクターレベル-33%、その他-20
- 地域別北米-35%、欧州-32%、アジア太平洋-25%、中南米-6%、中東・アフリカ-2
報告書に掲載された企業一覧
o アボット・ラボラトリーズ（米国）。
o HILL-ROM HOLDINGS, INC.（米国）。
o Drägerwerk AG & Co.KGaA（ドイツ）。
o エドワーズライフサイエンス株式会社（米国）。
o オムロン株式会社（日本）。
o Masimo Corporation (米国),
o Compumedics Limited (オーストラリア),
o Shenzhen Mindray Bio-Medical Electronics Co.(中国)。
o 日本光電工業株式会社（日本）。
o Natus Medical（米国）、Medtronic plc（アイルランド）。
o Koninklijke Philips N.V. (オランダ),
o GEヘルスケア（米国）、ゲティンゲAB（スウェーデン）。
o ボストン・サイエンティフィック・コーポレーション（米国）。
o Dexcom, Inc.（米国）。
o ノニン（米国）。
o BIOTRONIK（ドイツ）。
o SCHILLER（スイス）。
o バイオテレメトリー社(米国)

調査対象
本レポートでは、患者監視装置市場を製品、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会や課題を分析し、市場リーダー向けの競争環境についても詳細に記載しています。さらに、個々の成長傾向に関してマイクロマーケットを分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握することができ、ひいてはより大きな市場シェアを獲得するのに役立つものと思われます。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場での存在感を高めることができます。

本レポートでは、以下のポイントに関する洞察を提供しています。
市場浸透度。患者監視装置市場のトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報
製品開発/イノベーション。患者監視装置市場における今後の動向、研究開発活動、製品発売に関する詳細な洞察
市場開発。有利な新興地域に関する包括的な情報
市場の多様化。患者監視装置市場における新製品、成長地域、最近の開発に関する徹底的な情報
競争力のある評価。市場セグメント、成長戦略、収益分析、主要な市場プレイヤーの製品に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
TABLE 1 INCLUSIONS AND EXCLUSIONS 45
1.3 STUDY SCOPE 46
FIGURE 1 PATIENT MONITORING DEVICES MARKET 46
FIGURE 2 PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY 46
1.4 YEARS CONSIDERED 47
1.5 CURRENCY CONSIDERED 47
1.6 STAKEHOLDERS 47
1.7 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.2 RESEARCH DESIGN 49
FIGURE 3 PATIENT MONITORING DEVICES MARKET: RESEARCH DESIGN 49
2.2.1 SECONDARY DATA 50
2.2.2 PRIMARY DATA 51
FIGURE 4 PRIMARY SOURCES 51
2.2.2.1 Key data from primary sources 52
2.2.2.2 Insights from primary experts 52
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 53
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 53
2.3 MARKET SIZE ESTIMATION 54
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 54
FIGURE 8 TOP-DOWN APPROACH 55
2.4 DATA TRIANGULATION 57
FIGURE 9 DATA TRIANGULATION METHODOLOGY 57
2.5 MARKET SHARE ESTIMATION 58
2.6 RESEARCH ASSUMPTIONS 58
2.7 LIMITATIONS 58
2.8 RISK ASSESSMENT 59
TABLE 2 LIMITATIONS AND ASSOCIATED RISKS 59
3 EXECUTIVE SUMMARY 60
FIGURE 10 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 60
FIGURE 11 PATIENT MONITORING DEVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 61
FIGURE 12 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 62
4 PREMIUM INSIGHTS 63
4.1 PATIENT MONITORING DEVICES MARKET OVERVIEW 63
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS AND RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR PATIENT MONITORING DEVICES 63
4.2 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY & PRODUCT 64
FIGURE 14 JAPAN HOLDS LARGEST HIGHEST SHARE OF APAC MARKET 64
4.3 PATIENT MONITORING DEVICES MARKET SHARE, BY END USER 65
FIGURE 15 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING 2022–2027 65
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT MONITORING DEVICES MARKET 65
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST RATE DURING 2022–2027 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 17 PATIENT MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing technological advancements and innovations 67
5.2.1.1.1 Increased user-centric designs for wearable devices 67
5.2.1.1.2 Growing use of non-invasive hemodynamic monitoring 68
5.2.1.1.3 Rising use of digital data sensors 68
5.2.1.1.4 Growing use of mobile-grade EEG devices 69
5.2.1.2 Rising prevalence of chronic diseases 69
5.2.1.3 Availability of wireless monitoring devices 71
TABLE 3 RECENT PRODUCT INNOVATIONS IN PATIENT MONITORING DEVICES MARKET 72
5.2.1.4 Growing preference for wearable patient monitoring devices, biosensors, and smart implants 72
5.2.1.5 Growing investments, funds, and grants in healthcare systems 73
5.2.2 RESTRAINTS 74
5.2.2.1 Risks associated with invasive monitoring devices 74
5.2.2.2 High cost of patient monitoring products and inadequate reimbursement 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices 75
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings 76
5.2.4 CHALLENGES 76
5.2.4.1 Lack of skilled healthcare professionals 76
5.2.4.2 Increased pricing pressure on market players 77
5.3 VALUE CHAIN ANALYSIS 78
FIGURE 18 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 78
5.4 ECOSYSTEM ANALYSIS 79
5.5 REGULATORY ANALYSIS 79
5.5.1 NORTH AMERICA 79
5.5.1.1 US 79
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 80
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 80
5.5.1.2 Canada 80
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 81
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 81
5.5.2 EUROPE 82
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 83
5.5.3 ASIA PACIFIC 84
5.5.3.1 Japan 84
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 84
5.5.3.2 China 85
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 85
5.5.3.3 India 86
5.6 TRADE ANALYSIS 87
TABLE 9 IMPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION) 87
TABLE 10 EXPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION) 87
5.7 KEY CONFERENCES AND EVENTS IN 2022–2023 88
TABLE 11 DETAILED LIST OF MAJOR CONFERENCES AND EVENTS 88
6 PATIENT MONITORING DEVICES MARKET, BY PRODUCT 89
6.1 INTRODUCTION 90
TABLE 12 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90
6.2 BLOOD GLUCOSE MONITORING SYSTEMS 91
TABLE 13 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 91
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION) 92
6.2.1 SELF-MONITORING BLOOD GLUCOSE SYSTEMS 92
6.2.1.1 Rising adoption of integrated glucose monitoring systems to drive growth 92
TABLE 16 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 93
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS 94
6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring systems to drive market growth 94
TABLE 17 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 95
6.3 CARDIAC MONITORING DEVICES 95
TABLE 18 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 20 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 96
6.3.1 ECG DEVICES 97
6.3.1.1 Low cost and wide applications of ECG devices to drive market growth 97
TABLE 21 ECG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 98
6.3.2 IMPLANTABLE LOOP RECORDERS 98
6.3.2.1 High cost and limited applications limit growth 98
TABLE 22 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
6.3.3 EVENT MONITORS 99
6.3.3.1 Emergence of portable and wireless event monitors to drive market growth 99
TABLE 23 EVENT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 100
6.3.4 MCT MONITORS 100
6.3.4.1 Availability of alternate technologies likely to hinder market growth 100
TABLE 24 MCT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 101
6.3.5 SMART/WEARABLE ECG MONITORS 101
6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors 101
TABLE 25 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS 102
TABLE 26 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
6.4 MULTI-PARAMETER MONITORING DEVICES 103
TABLE 27 MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 28 MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 29 MULTI-PARAMETER MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 104
6.4.1 LOW-ACUITY MONITORING DEVICES 104
6.4.1.1 Increasing adoption of low-acuity monitoring devices to improve care in general wards drives market growth 104
TABLE 30 LOW-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 105
6.4.2 MID-ACUITY MONITORING DEVICES 105
6.4.2.1 Rising geriatric population is likely to increase market growth 105
TABLE 31 MID-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 105
6.4.3 HIGH-ACUITY MONITORING DEVICES 106
6.4.3.1 Increasing partnerships between manufacturers and hospitals drive device sales 106
TABLE 32 HIGH-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 106
6.5 RESPIRATORY MONITORING DEVICES 106
TABLE 33 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 34 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 107
TABLE 35 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 108
6.5.1 PULSE OXIMETERS 108
6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth 108
TABLE 36 PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 109
6.5.2 SPIROMETERS 109
6.5.2.1 Technological advancements to increase the adoption of spirometers 109
TABLE 37 SPIROMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 110
6.5.3 CAPNOGRAPHS 110
6.5.3.1 Product development and growing commercial acceptance to drive market growth 110
TABLE 38 CAPNOGRAPHS MARKET, BY REGION, 2020–2027 (USD MILLION) 111
6.5.4 PEAK FLOW METERS 111
6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices hinders market growth 111
TABLE 39 PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION) 112
6.6 TEMPERATURE MONITORING DEVICES 112
TABLE 40 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 41 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 42 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 113
6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES 113
6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth 113
TABLE 43 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS 114
TABLE 44 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 115
6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES 115
6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices 115
TABLE 45 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 116
6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES 116
6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand 116
TABLE 46 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS 117
TABLE 47 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 117
6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES 118
6.6.4.1 Risk of bloodstream infections associated with catheter usage hinders market for invasive devices 118
TABLE 48 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 118
6.6.5 SMART TEMPERATURE MONITORING PATCHES 119
6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth 119
TABLE 49 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS 119
TABLE 50 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 120
6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES 120
TABLE 51 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 52 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 121
TABLE 53 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 121
6.7.1 HEMODYNAMIC MONITORS 122
6.7.1.1 Influx of VC funding to drive market growth 122
TABLE 54 HEMODYNAMIC MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 122
6.7.2 BLOOD PRESSURE MONITORS 123
6.7.2.1 Development of wearable blood pressure monitors to drive market growth 123
TABLE 55 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 123
TABLE 56 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 124
6.7.3 DISPOSABLES 124
6.7.3.1 Growing number of surgical procedures to drive growth in disposables market 124
TABLE 57 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 124
6.8 FETAL & NEONATAL MONITORING DEVICES 125
TABLE 58 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 59 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 125
TABLE 60 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 126
6.8.1 FETAL MONITORING DEVICES 126
6.8.1.1 Rising prevalence of obstetric complications, growing pre-term birth rate drive market growth 126
TABLE 61 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS 128
TABLE 62 FETAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 128
6.8.2 NEONATAL MONITORING DEVICES 128
6.8.2.1 Rising number of neonatal care facilities worldwide to drive market 128
TABLE 63 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 129
6.9 NEUROMONITORING DEVICES 129
TABLE 64 NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 65 NEUROMONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 130
TABLE 66 NEUROMONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 131
6.9.1 EEG MACHINES 131
6.9.1.1 Growing applications and technological advancements form key market growth drivers 131
TABLE 67 EEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION) 132
6.9.2 EMG MACHINES 132
6.9.2.1 Availability of reimbursements for EMG-assisted surgeries boosts product demand 132
TABLE 68 EMG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION) 133
6.9.3 CEREBRAL OXIMETERS 133
6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth 133
TABLE 69 CEREBRAL OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 134
6.9.4 ICP MONITORS 134
6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs support adoption of ICP monitors 134
TABLE 70 ICP MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 135
6.9.5 MEG MACHINES 135
6.9.5.1 High implementation and maintenance costs of MEG devices likely to hinder market growth 135
TABLE 71 MEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION) 136
6.9.6 TCD MACHINES 136
6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth 136
TABLE 72 TCD MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION) 136
6.10 WEIGHT MONITORING DEVICES 137
TABLE 73 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 74 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 137
TABLE 75 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 138
6.10.1 DIGITAL WEIGHT MONITORING DEVICES 138
6.10.1.1 Consumer preference for digital scales—a key market driver 138
TABLE 76 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 138
6.10.2 ANALOG WEIGHT MONITORING DEVICES 139
6.10.2.1 Rising prevalence of obesity and low cost of analog scales support market growth 139
TABLE 77 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 139
6.11 OTHER PATIENT MONITORING DEVICES 140
TABLE 78 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 140
TABLE 79 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 141
TABLE 80 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 141
TABLE 81 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 142
7 PATIENT MONITORING DEVICES MARKET, BY END USER 143
7.1 INTRODUCTION 144
TABLE 82 PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 144
7.2 HOSPITALS 144
7.2.1 HOSPITALS TO DOMINATE END-USER MARKET 144
TABLE 83 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 145
7.3 AMBULATORY SURGERY CENTERS 145
7.3.1 COST-EFFECTIVENESS AND CONVENIENCE DRIVE DEMAND FOR AMBULATORY CARE 145
TABLE 84 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION) 146
7.4 HOME CARE SETTINGS 146
7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 146
TABLE 85 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 147
7.5 OTHER END USERS 147
TABLE 86 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 148
8 PATIENT MONITORING DEVICES MARKET, BY REGION 149
8.1 INTRODUCTION 150
TABLE 87 PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 150
8.2 NORTH AMERICA 151
FIGURE 21 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT 151
TABLE 88 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 89 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152
TABLE 90 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 91 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 92 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 93 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 94 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 95 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 96 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 97 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 98 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 99 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 157
8.2.1 US 157
8.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth 157
TABLE 100 VC FUNDING IN THE PATIENT MONITORING DEVICES MARKET IN THE US 158
TABLE 101 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
TABLE 102 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 103 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 104 US: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 105 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 106 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 107 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 108 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 109 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 110 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
8.2.2 CANADA 163
8.2.2.1 Growing public-private funding for research to drive market growth 163
TABLE 111 RESEARCH GRANTS IN THE PATIENT MONITORING DEVICES MARKET IN CANADA 163
TABLE 112 RECENT DEVELOPMENTS IN THE CANADIAN PATIENT MONITORING DEVICES MARKET 164
TABLE 113 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 114 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 115 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 116 CANADA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 117 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 118 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 119 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 120 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 121 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 122 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
8.3 EUROPE 170
TABLE 123 PRODUCT APPROVALS IN THE EUROPEAN PATIENT MONITORING DEVICES MARKET 170
TABLE 124 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
TABLE 125 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 171
TABLE 126 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 127 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 128 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 129 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 130 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 131 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 132 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 133 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 134 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 135 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 176
8.3.1 GERMANY 176
8.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth 176
TABLE 136 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 177
TABLE 137 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 138 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 139 GERMANY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 140 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 141 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 142 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 143 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 144 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 145 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
8.3.2 UK 182
8.3.2.1 Increasing public & private investments contribute to market growth 182
TABLE 146 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 183
TABLE 147 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 148 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 149 UK: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 150 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 151 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 152 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 153 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 154 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 155 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
8.3.3 FRANCE 187
8.3.3.1 Statutory health insurance system to support market growth 187
TABLE 156 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 188
TABLE 157 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 158 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 159 FRANCE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 160 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 161 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 162 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 163 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 164 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 165 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
8.3.4 ITALY 193
8.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices 193
TABLE 166 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 194
TABLE 167 ITALY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 168 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 169 ITALY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 170 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 171 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 172 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 173 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 174 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 175 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
8.3.5 SPAIN 199
8.3.5.1 Growing number of surgical procedures to drive market growth in Spain 199
TABLE 176 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 200
TABLE 177 SPAIN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 178 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 179 SPAIN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 180 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 181 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 182 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 183 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 184 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 185 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
8.3.6 REST OF EUROPE 205
TABLE 186 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN THE PATIENT MONITORING DEVICES MARKET IN THE ROE 205
TABLE 187 ROE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 206
TABLE 188 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 189 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 190 ROE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 191 ROE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 192 ROE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 193 ROE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 194 ROE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 195 ROE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 196 ROE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 211

ページTOPに戻る

Table of Contents

Summary

The patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022. The growth of the market is mainly attributed to greater adoption of biosensors and connected care devices and higher demand for home-based or home-use products. However, the high cost associated with novel and advanced monitoring devices is expected to limit the market growth.

“In product segment, blood glucose monitoring systems segment will undergo a significant growth by 2027.”

Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices. The substantial growth of the segment is attributed to the technological advancements and ongoing product approval of continuous glucose monitoring systems, benefits offered by continuous monitoring systems over self-monitoring systems in the market. Continuous glucose monitoring systems offer a wide range of advantages over self-monitoring blood glucose systems, such as non-invasive detection shortened detection time, and reduced cost. These advantages among several other advantages offered by the continuous glucose monitoring systems will lead to the growth of this product segment.

“By end-user hospitals segment is anticipated to account for the major share of the patient monitoring devices market,” `
By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end users. The demand growth among hospitals is attributed to the momentous availability of state-of-the-art services for patient treatment, diagnosis, as well as trained personnel, and disease management, that has ensured a stable demand for increasing number of hospitals in major countries and the hospital-based care. More diagnostic and screening procedures are carried out in hospitals, promoting to the increased market share. The influx of patients is usually higher in hospitals as compared to other healthcare settings, which is another key driver for segment growth.

“By Region, Asia Pacific Patient Monitoring Devices Market is anticipated to grow at the highest CAGR by 2027.”
The Asia Pacific market will grow at the highest CAGR during the forecast period majorly due to the rising healthcare expenditure, heavy burden of infectious diseases, and increasing geriatric population along with favourable public and private contribution to overall healthcare infrastructure. Apart from this, the increase in the number of ambulatory surgical centers and development of infrastructure in hospitals the APAC region is expected to propel the patient monitoring devices market.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%
List of Companies Profiled in the Report
o Abbott Laboratories (US),
o HILL-ROM HOLDINGS, INC. (US),
o Drägerwerk AG & Co. KGaA (Germany),
o Edwards Lifesciences Corporation (US),
o OMRON Corporation (Japan),
o Masimo Corporation (US),
o Compumedics Limited (Australia),
o Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China),
o Nihon Kohden Corporation (Japan),
o Natus Medical (US), Medtronic plc (Ireland),
o Koninklijke Philips N.V. (Netherlands),
o GE Healthcare (US), Getinge AB (Sweden),
o Boston Scientific Corporation (US),
o Dexcom, Inc. (US),
o Nonin (US),
o BIOTRONIK (Germany),
o SCHILLER (Switzerland),
o BioTelemetry, Inc. (US)

Research Coverage
This report studies the patient monitoring devices market based on product, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the patient monitoring devices market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the patient monitoring devices market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the patient monitoring devices market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?